Heather Stitely

Heather Stitely serves as the Executive Director of Account Management at Abeona Therapeutics, focusing on the commercialization of ZEVASKYN, a cell-based gene therapy for Recessive Dystrophic Epidermolysis Bullosa. Previously, Stitely held the position of Senior Director of Account Management at Bristol Myers Squibb, overseeing a significant team and managing accounts across multiple prestigious treatment sites. With over 16 years of experience at Celgene, Stitely advanced through various roles, including Director of Commercial Learning and District Sales Manager, contributing to successful product launches and training initiatives in hematology and oncology. Early career experience includes roles at Novartis, SmithKline Beecham Corporation, and Simon & Schuster, following a Bachelor of Arts degree from St. Bonaventure University.